Introduction {#sec1-0300060519847345}
============

Gallstones occur in patients worldwide, but are especially common in western countries.^[@bibr1-0300060519847345]^ Several factors have been reported to play roles in the formation of gallstones, including bacterial infections in the gallbladder and bile ducts.^[@bibr2-0300060519847345]^ Gallstones also cause various clinical conditions, such as acute cholecystitis, chronic cholecystitis, jaundice related to bile duct obstruction, and acute pancreatitis.^[@bibr3-0300060519847345]^

*Helicobacter pylori* is a Gram-negative bacillus thought to infect more than half the global population. *H. pylori* has primarily been identified in the stomach and has been related to several diseases, including duodenal ulcer, chronic gastritis, non-Hodgkin's lymphoma of the stomach, and gastric adenocarcinoma.^[@bibr4-0300060519847345][@bibr5-0300060519847345][@bibr6-0300060519847345][@bibr7-0300060519847345]--[@bibr8-0300060519847345]^ However, increasing numbers of studies have investigated localizations of *H. pylori* outside the stomach and diseases potentially related to such infections.^[@bibr9-0300060519847345]^ *H. pylori* was first described in the gallbladder mucosa in patients with gallstones 1996, and a relationship between *H. pylori* and gallstone formation was reported, as in the stomach.^[@bibr10-0300060519847345]^ However, despite subsequent reports of a relationship between *H. pylori* and chronic cholecystitis, no mechanism has yet been identified.^[@bibr11-0300060519847345],[@bibr12-0300060519847345]^ Importantly in this regard, it remains unclear if *H. pylori* reaches the gallbladder and biliary tree via an ascending route from the duodenum, or via the portal venous system.^[@bibr13-0300060519847345],[@bibr14-0300060519847345]^

Given the conflicting reports regarding the relationship between *H. pylori* infections and gallstone formation, this study aimed to investigate the relationships between *H. pylori* in the stomach and gallbladder and the occurrence of gallstones.

Methods {#sec2-0300060519847345}
=======

Patients {#sec3-0300060519847345}
--------

This prospective, case-control study reviewed a total of 732 patients who underwent cholecystectomy for any reason at Istanbul Training and Research Hospital between September 2015 and May 2018. Exclusion criteria were cholecystectomy performed because of acute cholecystitis, pregnancy, and patients who did not wish to participate in the study. Indications for cholecystectomy in the included patients were gallstones, pancreatic head cancer, or hepatic resection. Patients were ordered according to the date of cholecystectomy and 60 patients were chosen at random using the [www.random.org](http://www.random.org) website. Written informed consent was obtained from each patient and the study protocol was approved by the local Ethics Committee.

Gallbladders excised during cholecystectomy were placed in 10% buffered formaldehyde solution and sent to the pathology laboratory for routine pathology examination and investigation of *H. pylori* using Giemsa staining ([Figure 1](#fig1-0300060519847345){ref-type="fig"}). The patients were then separated into two groups according to the presence or absence of *H. pylori* in the gallbladder. Patient records included information on age, sex, pathology report and *H. pylori* status in the stomach if gastroscopy had been applied preoperatively, gallbladder wall thickness, cholesterolosis, intestinal metaplasia, activation, and pyloric metaplasia.

![Gallbladder biopsy stained for *H. pylori* using Giemsa staining (magnification ×100). Box shows representative *H. pylori* staining (magnification ×400).](10.1177_0300060519847345-fig1){#fig1-0300060519847345}

Statistical analysis {#sec4-0300060519847345}
--------------------

Data were analyzed using IBM SPSS Statistics for Windows, Version 22.0 software (IBM Corp., Armonk, NY, USA). Descriptive statistics were given as mean ± standard deviation (SD), median (maximum, minimum), number (n), and percentage (%). Conformity of the data to a normal distribution was assessed using the Kolmogorov--Smirnov test. Quantitative independent data were analyzed using the Mann--Whitney U-test. Qualitative independent data were analyzed by the χ^2^ test, or by Fisher's test if the χ^2^ test conditions were not met. A value of *P* \< 0.05 was accepted as statistically significant.

Results {#sec5-0300060519847345}
=======

A total of 60 patients were included in the final evaluation (34 women, 26 men, mean age 56.0 ± 11.7 years). The study was limited to 60 patients because of financial restrictions. Twenty-seven patients had gallstones and 33 did not. Group 1 comprised 52 patients without *H. pylori* in the gallbladder and Group 2 comprised eight patients with *H. pylori* in the gallbladder. There was no significant difference between the groups in terms of age, sex, wall thickness, presence of gallstones, rate of intestinal metaplasia, rate of activation, rate of previous stomach biopsy, or rate of gastritis in previous stomach biopsy ([Table 1](#table1-0300060519847345){ref-type="table"}).

###### 

Characteristics of patients according to gallbladder *H. pylori* status.

![](10.1177_0300060519847345-table1)

                            Gallbladder *H. pylori* (−)   Gallbladder *H. pylori* (+)   *P* value                            
  ------------------------- ----------------------------- ----------------------------- ----------- ---------- -------- ---- --------
  Age                       55.8±12.1                                                   58          57.4±9.6            60   0.524
  Sex                                                                                                                        
   Female                   29                            55.8%                                     5          62.5%         0.721
   Male                     23                            44.2%                                     3          37.5%         
  Wall thickness (mm)       3.8±3.3                                                     3           3.1±1.1             3    0.508
  Gallstones                                                                                                                 
   Absent                   28                            53.8%                                     5          62.5%         0.647
   Present                  24                            46.2%                                     3          37.5%         
  Cholesterolosis                                                                                                            
   Absent                   44                            84.6%                                     8          100.0%        0.582
   Present                  8                             15.4%                                     0          0.0%          
  Intestinal metaplasia                                                                                                      
   Absent                   47                            90.4%                                     7          87.5%         \>0.95
   Present                  5                             9.6%                                      1          12.5%         
  Activation                                                                                                                 
   Absent                   38                            73.1%                                     6          75.0%         0.909
   Present                  14                            26.9%                                     2          25.0%         
  Pyloric metaplasia                                                                                                         
   Absent                   39                            75.0%                                     8          100.0%        0.182
   Present                  13                            25.0%                                     0          0.0%          
  Previous stomach biopsy                                                                                                    
   Absent                   40                            76.9%                                     6          75.0%         0.222
   Present                  10                            23.1%                                     4          25.0%         
  Gastritis                                                                                                                  
   Absent                   1                             8.3%                                      0          0.0%          \>0.95
   Present                  9                             91.7%                                     4          100.0%        

Fourteen patients underwent preoperative gastroscopy and biopsy for *H. pylori* detection. There was no significant difference between patients with and without *H. pylori* in the stomach in relation to the detection of gallstones.

Out of five patients with *H. pylori*-positive gastritis (confirmed by biopsy), four were also positive for *H. pylori* on gallbladder biopsy, while all nine patients negative for *H. pylori* gastritis were also negative for gallbladder *H. pylori*, suggesting a significant correlation between stomach and gallbladder *H. pylori* status (*P* = 0.005) ([Table 2](#table2-0300060519847345){ref-type="table"})

###### 

Gallstones and *H. pylori* status according to presence of *H. pylori* in stomach biopsy

![](10.1177_0300060519847345-table2)

                                   Stomach *H. pylori* (−)   Stomach *H. pylori* (+)   *P* value                   
  -------------------------------- ------------------------- ------------------------- ----------- ------- ------- --------
  Gallstones                       Absent                    4                            44.4%    3       60.0%   \<0.95
  Present                          5                            55.6%                  2           40.0%           
  Gallbladder *H. pylori* status   Absent                    9                         100.0%      1       20.0%    0.005
  Present                          0                         0.0%                      4           80.0%           

In relation to the possible route of spread, 24 of the 33 patients without gallstones, including four of the five patients with *H. pylori* in the gallbladder, had a history of preoperative endoscopic retrograde cholangiography (ERCP), compared with only 2 of the 27 patients who underwent cholecystectomy because of gallbladder stones.

Discussion {#sec6-0300060519847345}
==========

Many recent studies have investigated the occurrence of *H. pylori* outside the stomach, e.g., in the skin, nose, and gallbladder,^[@bibr9-0300060519847345],[@bibr15-0300060519847345]^ while other studies have evaluated the statuses of other *Helicobacter* strains within the gallbladder.^[@bibr10-0300060519847345],[@bibr11-0300060519847345]^

Fatemi et al. compared *Helicobacter* strains between patients without gallstones and those with acute cholecystitis and chronic cholecystitis associated with gallstones. *H. pylori* was observed at a significantly higher rate in cases with acute cholecystitis associated with gallstones compared with the other cases, and there was no relationship with other *Helicobacter* strains.^[@bibr16-0300060519847345]^ A meta-analysis that reviewed studies of the relationship between *H. pylori* and gallstones and cholecystectomy reported that *H. pylori* was more common in patients with chronic cholecystitis and gallstones compared with the control group (24.98% vs. 8.28%, *P*\<0.05).^[@bibr17-0300060519847345]^ Another meta-analysis also demonstrated a relationship between *H. pylori* in the gallbladder and cholelithiasis.^[@bibr18-0300060519847345]^ Zhou et al.^[@bibr14-0300060519847345]^ found *H. pylori* in 20% of chronic cholecystitis cases, and also emphasized that gallbladder metaplasia and pre-malignant lesions such as adenomyomatosis were more frequent in patients positive for gallbladder *H. pylori*. In another study, Hassan et al.^[@bibr19-0300060519847345]^ reported that *H. pylori* infection aggravated potentially precancerous mucosal lesions.

In contrast to many studies, a retrospective study^[@bibr15-0300060519847345]^ of 45 cases including cholecystectomy samples detected *H. pylori*-positivity in the gallbladder in 40% of patients without gallstones and 20% of those with gallstones. However, this difference was not significant and no relationship could be established between *H. pylori*-positivity and the occurrence of gallstones. Moreover, no *H. pylori* gallbladder infection was noted in 10 patients with ulceration of the gallbladder.^[@bibr15-0300060519847345]^ Similarly, the current study found no relationship between *H. pylori*-positivity in the gallbladder and gallstones, or the development of cholesterolosis, intestinal metaplasia, pyloric metaplasia, and activation.

Previous studies reported that *H. pylori* was more prevalent in eastern countries and showed no sex difference, but was related to age, with a particular increase in colonization rates above the age of 70 years.^[@bibr20-0300060519847345][@bibr21-0300060519847345]--[@bibr22-0300060519847345]^ The mean age of the patients with gallbladder *H. pylori*-positivity in the current study was 57.4 years, which was not significantly different from that of the patients who were *H. pylori*-negative in the gallbladder.

There is currently insufficient evidence regarding the route whereby *H. pylori* settles in the gallbladder. It may reach the gallbladder via an ascending route from the duodenum or via the portal circulation system.^[@bibr23-0300060519847345],[@bibr24-0300060519847345]^ A meta-analysis of patients undergoing ERCP reported that the procedure could result in contamination of the gallbladder with *Helicobacter* strains via the ascending pathway from the duodenum, leading to false-positive results.^[@bibr17-0300060519847345]^ In the current study, although four out of the five patients with *H. pylori* in the gallbladder without gallstones underwent preoperative ERCP, thus supporting its possible spread via the ascending pathway, no conclusions can be drawn about the route of spread in patients with gallstones who did not undergo ERCP.

An extensive retrospective study^[@bibr25-0300060519847345]^ that evaluated the relationship between the presence of *H. pylori* antibodies in the blood and gallstones found no relationship between the rates of gallstones in *H. pylori*-positive patients overall, but a significant negative correlation was observed in individuals aged \<45 years. The same study identified a significant relationship between gallbladder polyps and *H. pylori*-positivity.^[@bibr25-0300060519847345]^ Helaly et al.^[@bibr26-0300060519847345]^ reported a significant relationship between *H. pylori*-positivity in the stomach and the gallbladder, while another study also found a strong association between gallbladder and stomach *H. pylori*-positivity.^[@bibr14-0300060519847345]^ The current study found no significant relationship between the occurrence of gallstones and stomach *H. pylori*-positivity in patients with stomach biopsy results, but did confirm a significant relationship between stomach and gallbladder *H. pylori*-positivity.

This study had some limitations owing to its small size and limited variation, which meant that it was not possible to examine subgroups of patients with cancers of the hepatobiliary system and pre-malignant lesions because of the low patient numbers. In addition, *H. pylori* status was not measured in the bile ducts, thus limiting the information available in relation to the route of *H. pylori* spreading.

In contrast to several previous studies, the current results suggested that the rates of gallbladder *H. pylori*-positivity, as well as stomach *H. pylori*-positivity, were similar in patients with and without gallstones. However, there was a significant relationship between stomach and gallbladder *H. pylori* statuses. Although further studies with larger series are required, the present results indicate that *H. pylori* infection does not contribute to the development of gallstones.
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